Close

Soleno Therapeutics (SLNO) Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Soleno Therapeutics (SLNO) Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome
(NASDAQ: SLNO) Delayed: 37.34 -2 (5.08%)
Previous Close $39.34    52 Week High $ 
Open $38.20    52 Week Low $ 
Day High $38.53    P/E N/A 
Day Low $37.25    EPS $ 
Volume 269,361